The sp can sometimes be confounding given the robustness of the CT data across many years, phases and indications. One of the challenges that must be overcome is unscrupulous players in the space that undermine public and scientific confidence.
This article provides terrific context:
Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed ‘‘Stem Cell Treatments’’ for COVID-19. link below
https://www.cell.com/cell-stem-cell/pdf/S1934-5909(20)30201-0.pdf?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1934590920302010%3Fshowall%3Dtrue
For every impatient poster wishing that results were released 'yesterday', my strong preference is that the the team at MSB continue to apply the scientific rigour necessary to make the results irrefutable.
If and when, positive phase 3 trial results are reported, patience will be suitably rewarded.
GLTAH DYOR
V
Cell Therapy News/Articles, page-3901
-
- There are more pages in this discussion • 14,348 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |